ADAP Waiting List Update: 1,958 People in 9 States as of July 5
July 6, 2012
As of July 5, 2012, there are 1,958 individuals on ADAP waiting lists in nine states. This week, Alabama, Georgia, Louisiana and North Carolina saw increases in the number of clients on their waiting lists. Florida, Nebraska, and Virginia saw minor decreases, while Idaho and Montana's numbers remained steady. To see a list of states with access restrictions please visit NASTAD's website.
The total number of individuals on waiting lists has decreased 79 percent since a high of 9,298 individuals on September 1, 2011. Regular FY2011 and FY2012 ADAP funding, along with FY2011 emergency funds, have helped to alleviate some of the waiting lists and other cost containment measures. Additional funding is still needed to further decrease or stabilize the waiting lists.
FY2012 emergency funding for ADAPs, including both the $35 million in new funding that President Obama announced on World AIDS Day and the $40 million in continuation funding for FY2012, was anticipated to be awarded by July 1, 2012. The $35 million in new funding was available for all Part B grantees. Awards will be capped at $7 million with a minimum award of $50,000. The $40 million in continuation funding was available for competition only for the 30 Part B grantees that received FY2011 ADAP emergency funding. The new funding is expected to further reduce ADAP waiting lists and other cost containment measures currently in place.
Regarding FY2013 funding, the Senate Appropriations Committee approved a Labor-HHS-Education Appropriations bill that includes a $30 million increase for ADAP over FY2012 funding levels while continuing the $35 million announced on World AIDS Day as part of the ADAP base funding. President Obama's FY2013 budget proposal included a $67 million increase for ADAP over FY2012 levels, for a total of $1 billion. The President's FY2013 budget also includes the $35 million announced on World AIDS Day. The House is expected to mark-up their Labor-HHS Appropriations bill after the holiday recess.
As a result of the variability of ADAP enrollment and funding, waiting lists will likely remain and continue to fluctuate, particularly with increased efforts to identify new individuals living with HIV or re-engage individuals lost to care. Many ADAPs continue to struggle financially, including those without any cost-containment measures currently in place. Four ADAPs currently anticipate the need to implement cost-containment measures or a waiting list during the ADAP FY2012 grant year (began April 1, 2012).
ADAPs With Other Cost-Containment Strategies: Financial Eligibility (Instituted Since September 2009, as of April 19, 2012)
Six ADAPs have previously lowered their financial eligibility as part of their cost-containment plans since September 2009. Illinois, North Dakota, Ohio and South Carolina lowered their eligibility level to 300% FPL. Utah lowered their eligibility level to 250% FPL, and Arkansas lowered their eligibility level to 200% FPL. Previously, all states had FPLs of 400% and above. As a result of these measures, a total of 445 individuals in three states, Arkansas (99), Ohio (257), and Utah (89), were disenrolled. Illinois, North Dakota, and South Carolina grandfathered their clients that fell within the income levels into their programs. No other ADAPs currently anticipate further changes to their financial eligibility.
ADAPs With Other Cost-Containment Strategies (Instituted Since April 1, 2009, as of April 11, 2012)
Alabama: reduced formulary, capped enrollment
ADAPs Considering New/Additional Cost-Containment Measures (Before March 31, 2013***)
Alaska: reduce formulary
Access to Medications
Case management services are being provided to ADAP waiting list clients through ADAP (1 ADAP), Part B (5 ADAPs), contracted agencies (7 ADAPs) and other agencies, including other Parts of Ryan White (4 ADAPs).
For clients on ADAP waiting lists who are currently on or in need of medications, nine ADAP waiting list states confirm that ADAP waiting list clients are receiving medications through either pharmaceutical company patient assistance programs (PAPs) Welvista, or other mechanisms available within the state.
This article was provided by National Alliance of State and Territorial AIDS Directors. Visit NASTAD's website to find out more about their activities and publications.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)